title: Celltrion's infliximab copy shows path to biosimilars in US.
authors.forename: Eva
authors.initials: E
authors.lastname: von Schaper
mesh_terms: D059451:Biosimilar Pharmaceuticals; D017277:Drug Approval; D006801:Humans; D000069285:Infliximab / Q000145:classification* / Q000627:therapeutic use*; D056910:Republic of Korea; D014481:United States
chemical_list: D059451:Biosimilar Pharmaceuticals; D000069285:Infliximab